---
title: "KHPG: \"KH813 Injection\" drug clinical trial approved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246662783.md"
description: "KHPG announced that its wholly-owned subsidiary Chengdu KHPG Biotechnology Co., Ltd. has received approval from the National Medical Products Administration to conduct clinical trials for \"KH813 Injection.\" KH813 Injection is a biosimilar of Pembrolizumab, primarily used for the treatment of various advanced solid tumors, capable of blocking the interaction between PD-1 and PD-L1, PD-L2, thereby enhancing anti-tumor immune response"
datetime: "2025-06-30T11:37:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246662783.md)
  - [en](https://longbridge.com/en/news/246662783.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246662783.md)
---

# KHPG: "KH813 Injection" drug clinical trial approved

According to the Zhitong Finance APP, KHPG (002773.SZ) announced that its wholly-owned subsidiary Chengdu KHPG Biotechnology Co., Ltd. ("KHPG Biotechnology") has received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration, involving the product: "KH813 Injection".

KH813 Injection is a biosimilar of Pembrolizumab developed by KHPG Biotechnology. Pembrolizumab is a monoclonal antibody that can bind to the PD-1 receptor, blocking the interaction between PD-1 and PD-L1, PD-L2, thereby relieving the immune response suppression mediated by the PD-1 pathway, including anti-tumor immune responses. Pembrolizumab is mainly used for the treatment of various advanced solid tumors (such as non-small cell lung cancer, melanoma, etc.), which can prolong survival and improve the quality of life of patients

### Related Stocks

- [002773.CN](https://longbridge.com/en/quote/002773.CN.md)

## Related News & Research

- [Oops! Someone Forgot To Tell Jeanine Pirro About Trump's $1.8B J6 Slush Fund](https://longbridge.com/en/news/286831031.md)
- [Trump Delivers Confused Rambling After Claiming ’Every Agency' Has 'Scum'](https://longbridge.com/en/news/287086760.md)
- [Obamacare Meltdown? Sharp ACA Enrollment Drop Expected As Pandemic-Era Subsidies End](https://longbridge.com/en/news/287067300.md)
- [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md)
- [Trump is waging a silent war on legal immigration](https://longbridge.com/en/news/287081964.md)